University of California, Los Angeles (UCLA), United States
Dr. Lili Yang received her Ph.D. degree in Biology from the California Institute of Technology (Caltech), studying with Dr. David Baltimore. She is currently Professor of Microbiology, Immunology and Molecular Genetics at the University of California, Los Angeles (UCLA). Her research laboratory at UCLA studies cancer immunotherapy, with a special focus on developing gene and cell-based immunotherapy for cancer (https://www.liliyanglab.com/). So far her work has resulted in over 80 publications, 28 patents, 2 clinical trials, and 2 biotech startups.
In recognition of her scientific achievements, Dr. Lili Yang has received multiple prestigious awards, including a TR35 Award from the MIT Technology Review Magazine, a Director’s New Innovator Award from the National Institute of Health (NIH), and an Outstanding New Investigator Award from the American Society of Gene & Cell Therapy (ASGCT).
Dr. Lili Yang is also widely recognized for her biotech accomplishments. She has been named Women in Biopharma by Endpoints News in 2022, and Top Women in Academic Entrepreneurship by BIOS in 2023.
MODULATING THE IMMUNE SYSTEM TO FIGHT DISEASE
Thursday, June 12, 2025
2:00 PM - 3:30 PM HK Time
Thursday, June 12, 2025
2:55 PM - 3:05 PM HK Time